Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.
- DOI
- 10.1002/hem3.70073
- Published
- 2025 Jan
- Container
- HemaSphere
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70073,
title = {Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.},
author = {Rombaut D and Sandmann S and Tekath T and Crouch S and de Graaf AO and Smith A and Painter D and Kosmider O and Tobiasson M and Lennartsson A and van der Reijden BA and Park S and D'Aveni M and Slama B and Clappier E and Fenaux P and Adès L and van de Loosdrecht A and Langemeijer S and Symeonidis A and Čermák J and Preudhomme C and Savic A and Germing U and Stauder R and Bowen D and van Marrewijk C and Bernard E and de Witte T and Varghese J and Hellström-Lindberg E and Dugas M and Martens J and Malcovati L and Jansen JH and Fontenay M and MDS‐RIGHT consortium},
year = {2025},
journal = {HemaSphere},
doi = {10.1002/hem3.70073},
url = {https://doi.org/10.1002/hem3.70073}
}RIS
TY - JOUR TI - Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes. AU - Rombaut D AU - Sandmann S AU - Tekath T AU - Crouch S AU - de Graaf AO AU - Smith A AU - Painter D AU - Kosmider O AU - Tobiasson M AU - Lennartsson A AU - van der Reijden BA AU - Park S AU - D'Aveni M AU - Slama B AU - Clappier E AU - Fenaux P AU - Adès L AU - van de Loosdrecht A AU - Langemeijer S AU - Symeonidis A AU - Čermák J AU - Preudhomme C AU - Savic A AU - Germing U AU - Stauder R AU - Bowen D AU - van Marrewijk C AU - Bernard E AU - de Witte T AU - Varghese J AU - Hellström-Lindberg E AU - Dugas M AU - Martens J AU - Malcovati L AU - Jansen JH AU - Fontenay M AU - MDS‐RIGHT consortium PY - 2025 JO - HemaSphere DO - 10.1002/hem3.70073 UR - https://doi.org/10.1002/hem3.70073 ER -
APA
D, R., S, S., T, T., S, C., AO, D. G., A, S., D, P., O, K., M, T., A, L., BA, V. D. R., S, P., M, D., B, S., E, C., P, F., L, A., A, V. D. L., S, L., A, S., J, Č., C, P., A, S., U, G., R, S., D, B., C, V. M., E, B., T, D. W., J, V., E, H., M, D., J, M., L, M., JH, J., M, F., & consortium, M. (2025). Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.. HemaSphere. https://doi.org/10.1002/hem3.70073
Source records
- pubmed · retrieved 2026-09-27T14:25:57.450Z